PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BMRN vs. JAZZ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BMRN and JAZZ is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

BMRN vs. JAZZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioMarin Pharmaceutical Inc. (BMRN) and Jazz Pharmaceuticals plc (JAZZ). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-26.11%
13.23%
BMRN
JAZZ

Key characteristics

Sharpe Ratio

BMRN:

-1.09

JAZZ:

0.13

Sortino Ratio

BMRN:

-1.37

JAZZ:

0.39

Omega Ratio

BMRN:

0.78

JAZZ:

1.05

Calmar Ratio

BMRN:

-0.58

JAZZ:

0.08

Martin Ratio

BMRN:

-1.85

JAZZ:

0.25

Ulcer Index

BMRN:

18.36%

JAZZ:

14.30%

Daily Std Dev

BMRN:

31.35%

JAZZ:

27.96%

Max Drawdown

BMRN:

-90.58%

JAZZ:

-96.90%

Current Drawdown

BMRN:

-58.71%

JAZZ:

-36.15%

Fundamentals

Market Cap

BMRN:

$11.74B

JAZZ:

$7.45B

EPS

BMRN:

$1.66

JAZZ:

$7.07

PE Ratio

BMRN:

37.10

JAZZ:

17.43

PEG Ratio

BMRN:

0.40

JAZZ:

0.84

Total Revenue (TTM)

BMRN:

$2.10B

JAZZ:

$2.98B

Gross Profit (TTM)

BMRN:

$1.63B

JAZZ:

$2.35B

EBITDA (TTM)

BMRN:

$455.03M

JAZZ:

$1.06B

Returns By Period

In the year-to-date period, BMRN achieves a -6.31% return, which is significantly lower than JAZZ's 0.07% return. Over the past 10 years, BMRN has underperformed JAZZ with an annualized return of -4.69%, while JAZZ has yielded a comparatively higher -2.88% annualized return.


BMRN

YTD

-6.31%

1M

-6.04%

6M

-27.26%

1Y

-34.11%

5Y*

-6.97%

10Y*

-4.69%

JAZZ

YTD

0.07%

1M

-1.57%

6M

14.10%

1Y

3.45%

5Y*

-4.00%

10Y*

-2.88%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BMRN vs. JAZZ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMRN
The Risk-Adjusted Performance Rank of BMRN is 66
Overall Rank
The Sharpe Ratio Rank of BMRN is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of BMRN is 77
Sortino Ratio Rank
The Omega Ratio Rank of BMRN is 55
Omega Ratio Rank
The Calmar Ratio Rank of BMRN is 1414
Calmar Ratio Rank
The Martin Ratio Rank of BMRN is 22
Martin Ratio Rank

JAZZ
The Risk-Adjusted Performance Rank of JAZZ is 4949
Overall Rank
The Sharpe Ratio Rank of JAZZ is 5353
Sharpe Ratio Rank
The Sortino Ratio Rank of JAZZ is 4444
Sortino Ratio Rank
The Omega Ratio Rank of JAZZ is 4444
Omega Ratio Rank
The Calmar Ratio Rank of JAZZ is 5252
Calmar Ratio Rank
The Martin Ratio Rank of JAZZ is 5252
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BMRN vs. JAZZ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for BioMarin Pharmaceutical Inc. (BMRN) and Jazz Pharmaceuticals plc (JAZZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BMRN, currently valued at -1.08, compared to the broader market-2.000.002.00-1.090.13
The chart of Sortino ratio for BMRN, currently valued at -1.37, compared to the broader market-4.00-2.000.002.004.00-1.370.39
The chart of Omega ratio for BMRN, currently valued at 0.78, compared to the broader market0.501.001.502.000.781.05
The chart of Calmar ratio for BMRN, currently valued at -0.58, compared to the broader market0.002.004.006.00-0.580.08
The chart of Martin ratio for BMRN, currently valued at -1.85, compared to the broader market-30.00-20.00-10.000.0010.0020.00-1.850.25
BMRN
JAZZ

The current BMRN Sharpe Ratio is -1.09, which is lower than the JAZZ Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of BMRN and JAZZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.00AugustSeptemberOctoberNovemberDecember2025
-1.09
0.13
BMRN
JAZZ

Dividends

BMRN vs. JAZZ - Dividend Comparison

Neither BMRN nor JAZZ has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BMRN vs. JAZZ - Drawdown Comparison

The maximum BMRN drawdown since its inception was -90.58%, smaller than the maximum JAZZ drawdown of -96.90%. Use the drawdown chart below to compare losses from any high point for BMRN and JAZZ. For additional features, visit the drawdowns tool.


-60.00%-55.00%-50.00%-45.00%-40.00%-35.00%AugustSeptemberOctoberNovemberDecember2025
-58.71%
-36.15%
BMRN
JAZZ

Volatility

BMRN vs. JAZZ - Volatility Comparison

BioMarin Pharmaceutical Inc. (BMRN) has a higher volatility of 8.50% compared to Jazz Pharmaceuticals plc (JAZZ) at 5.73%. This indicates that BMRN's price experiences larger fluctuations and is considered to be riskier than JAZZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
8.50%
5.73%
BMRN
JAZZ

Financials

BMRN vs. JAZZ - Financials Comparison

This section allows you to compare key financial metrics between BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab